par Borghgraef, Cindy 
;Libert, Yves ;Razavi, Darius ;Etienne, Anne-Marie;Delvaux, Nicole ;Reynaert, Christine
Référence Bulletin du cancer, 101, 9, page (866-875)
Publication Publié, 2014-09
;Libert, Yves ;Razavi, Darius ;Etienne, Anne-Marie;Delvaux, Nicole ;Reynaert, ChristineRéférence Bulletin du cancer, 101, 9, page (866-875)
Publication Publié, 2014-09
Article révisé par les pairs
| Résumé : | Objective. Various studies highlight cognitive impairments in cancer patients. This paper proposes a review of longitudinal controlled studies evaluating the efficacy of interventions aiming to reduce these cognitive impairments. Method. Longitudinal controlled studies evaluating the efficacy of interventions aiming to reduce cognitive impairments in adult cancer patients and published between 1993 and 2013 were identified, with the exception of studies that implied patients suffering from CNS tumor or metastasis. Results. Pharmacological interventions (n = 11) suggested the positive impact of modafinil on memory and executive functions. Non-pharmacological interventions (n = 10) suggested the positive impact of cognitive revalidation and stimulation programs, psycho-education and meditation on several memory, attentional and executive objective as well as subjective functions. Nonpharmacological interventions show more significant cognitive benefits than pharmacological interventions. Conclusion. Some longitudinal controlled studies support the usefulness of interventions aiming to reduce cognitive impairments in cancer patients. Further studies should evaluate the effectiveness of programs combining technics aiming to reduce cognitive impairments and psychotherapeutic technics aiming to support patients' coping with illness. |
